| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +50.00% | +0.64% | +1.27% | -0.64% | -1.81% | — |
| 14d | 4 | +75.00% | -2.79% | +1.26% | -4.04% | -6.45% | — |
| 30d | 4 | +75.00% | -16.20% | -9.16% | -7.04% | -10.30% | — |
| 60d | 4 | +100.00% | -22.26% | -18.85% | -3.41% | -3.48% | — |
| 90d | 4 | +100.00% | -14.20% | -14.65% | +0.45% | +1.25% | — |
| 180d | 4 | +0.00% | +8.58% | -0.15% | +8.73% | +5.44% | — |
| 1y | 4 | +75.00% | -0.21% | +18.59% | -18.80% | -21.99% | — |
| 2y | 4 | +0.00% | +29.94% | +41.28% | -11.35% | -12.29% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED |
|---|---|---|---|---|---|---|---|
| AMPH AMPHASTAR PHARMACEUTICALS, INC. | SALE President and General Counsel | 9,299 | $14.50 | $134.8K | 179,276 | Mar 17, 2020 | Mar 18, 2020 ↗ |
| AMPH AMPHASTAR PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 150,958 | — | — | 150,958 | Mar 16, 2020 | Mar 18, 2020 ↗ |
| AMPH AMPHASTAR PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 64,466 | — | — | 188,575 | Mar 16, 2020 | Mar 18, 2020 ↗ |
| AMPH AMPHASTAR PHARMACEUTICALS, INC. | SALE President and General Counsel | 7,893 | $13.03 | $102.8K | 124,109 | Mar 16, 2020 | Mar 18, 2020 ↗ |
| AMPH AMPHASTAR PHARMACEUTICALS, INC. | SALE President and General Counsel | 6,896 | $14.19 | $97.9K | 132,002 | Mar 15, 2020 | Mar 17, 2020 ↗ |
| AMPH AMPHASTAR PHARMACEUTICALS, INC. | SALE President and General Counsel | 6,853 | — | — | 46,944 | Feb 7, 2020 | Feb 7, 2020 ↗ |
| AMPH AMPHASTAR PHARMACEUTICALS, INC. | PURCHASE President and General Counsel | 6,853 | $14.40 | $98.7K | 145,751 | Feb 7, 2020 | Feb 7, 2020 ↗ |
| AMPH AMPHASTAR PHARMACEUTICALS, INC. | SALE President and General Counsel | 6,853 | $19.88 | $136.3K | 138,898 | Feb 7, 2020 | Feb 7, 2020 ↗ |
| AMPH AMPHASTAR PHARMACEUTICALS, INC. | SALE President and General Counsel | 21,933 | $19.83 | $435.0K | 138,898 | Feb 6, 2020 | Feb 7, 2020 ↗ |
| AMPH AMPHASTAR PHARMACEUTICALS, INC. | PURCHASE President and General Counsel | 21,933 | $14.40 | $315.8K | 160,831 | Feb 6, 2020 | Feb 7, 2020 ↗ |
| AMPH AMPHASTAR PHARMACEUTICALS, INC. | SALE President and General Counsel | 21,933 | — | — | 53,797 | Feb 6, 2020 | Feb 7, 2020 ↗ |
| AMPH AMPHASTAR PHARMACEUTICALS, INC. | SALE President and General Counsel | 15,615 | — | — | 75,730 | Feb 5, 2020 | Feb 7, 2020 ↗ |
| AMPH AMPHASTAR PHARMACEUTICALS, INC. | SALE President and General Counsel | 15,615 | $19.57 | $305.6K | 138,898 | Feb 5, 2020 | Feb 7, 2020 ↗ |
| AMPH AMPHASTAR PHARMACEUTICALS, INC. | PURCHASE President and General Counsel | 15,615 | $14.40 | $224.9K | 154,513 | Feb 5, 2020 | Feb 7, 2020 ↗ |
| AMPH AMPHASTAR PHARMACEUTICALS, INC. | SALE President and General Counsel | 25,000 | — | — | 9,149 | Jan 8, 2020 | Jan 10, 2020 ↗ |
| AMPH AMPHASTAR PHARMACEUTICALS, INC. | SALE President and General Counsel | 25,000 | $18.44 | $461.0K | 138,898 | Jan 8, 2020 | Jan 10, 2020 ↗ |
| AMPH AMPHASTAR PHARMACEUTICALS, INC. | PURCHASE President and General Counsel | 25,000 | $10.93 | $273.3K | 163,898 | Jan 8, 2020 | Jan 10, 2020 ↗ |